Major vascular resection in retroperitoneal sarcoma surgery.
Where this comes from
- Record sourced from PubMed, PMID 33812753.
- Also identified by DOI 10.1016/j.surg.2021.02.052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Major blood vessels may be invaded either by primary sarcomas arising from the vessel wall or by secondary infiltration of a retroperitoneal sarcoma. The involvement of major blood vessels is not considered to be an absolute contraindication for surgical resection. The main issue when evaluating a possible major vascular resection is to balance the possible surgical morbidity with the expected survival benefit. This is strictly related to the tumor's biology and clinical behavior and to the patient's performance status and comorbidities. A multidisciplinary approach in a specialized center is mandatory when approaching a possible oncovascular resection for retroperitoneal sarcoma, given the rarity and the heterogeneity of these tumors.
Medical subject headings
- Retroperitoneal Neoplasms
- Sarcoma
- Vascular Neoplasms
- Vascular Surgical Procedures